Corcept Therapeutics (CORT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
In his iconic song The Gambler, Kenny Rogers famously sang, “Every hand’s a winner, and every hand’s a loser.” This line ...
We’re now just days away from the ’24 elections, and what a race it’s been. Polls have been all over the place, and both ...
MicroStrategy Inc. (NASDAQ:MSTR), a stock considered an alternative to Bitcoin (CRYPTO: BTC) investment, received a bullish signal from moving average (MA) technical indicators. What happened: ...
The market focus, naturally, has been on FII selling this month. In the process, the street seems to have forgotten another ...
One challenge facing Carnival stock today is that because 2024 has been so strong, the company will have a tough act to ...
Vertiv Holdings is a strong investment option in the digital infrastructure sector with AI-driven data center demand and ...
There's a lot riding on Nvidia's upcoming financial report, and many shareholders are wondering whether the stock can ...
In a report released today, Mayank Tandon from Needham reiterated a Buy rating on EverQuote (EVER – Research Report), with a price target ...
On the bottom line, it flipped a $7.4 million loss to a profit of $29.9 million, or $0.16 a share, as the company also ...
This is the most efficient used Toyota hybrid you can get for under $20,000, and it's also a model that has always set the ...
Uber's Q3 results beat analyst expectations. JMP Securities sees opportunity for growth, raises target to $95. KeyBanc ...